Koselugo (selumetinib)
pCPA File Number:
22375
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of pediatric patients aged 2 years and above, with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas
Sponsor/Manufacturer:
Alexion Pharma GMBH
CADTH Project Number:
SR0764
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable